Authors:
BROLIDEN K
ABREU ER
ARNEBORN M
BOTTIGER M
Citation: K. Broliden et al., IMMUNITY TO MUMPS BEFORE AND AFTER MMR VACCINATION AT 12 YEARS OF AGEIN THE FIRST-GENERATION OFFERED THE 2-DOSE IMMUNIZATION PROGRAM, Vaccine, 16(2-3), 1998, pp. 323-327
Citation: K. Broliden et al., IMMUNITY TO MEASLES BEFORE AND AFTER MMR BOOSTER OR PRIMARY VACCINATION AT 12 YEARS OF AGE IN THE FIRST-GENERATION OFFERED THE 2-DOSE IMMUNIZATION PROGRAM, Scandinavian journal of infectious diseases, 30(1), 1998, pp. 23-27
Authors:
COTROPIA J
UGEN KE
KLIKS S
BROLIDEN K
BROLIDEN PA
HOXIE JA
SRIKANTAN V
WILLIAMS WV
WEINER DB
Citation: J. Cotropia et al., A HUMAN MONOCLONAL-ANTIBODY TO HIV-1 GP41 WITH NEUTRALIZING ACTIVITY AGAINST DIVERSE LABORATORY ISOLATES, Journal of acquired immune deficiency syndromes and human retrovirology, 12(3), 1996, pp. 221-232
Citation: T. Tolfvenstam et al., EVALUATION OF SEROLOGICAL ASSAYS FOR IDENTIFICATION OF PARVOVIRUS B19IMMUNOGLOBULIN-M, Clinical and diagnostic laboratory immunology, 3(2), 1996, pp. 147-150
Authors:
BROLIDEN K
HINKULA J
BRATT G
PERSSON C
OTERO A
EKSTROM A
SANDSTROM E
BROLIDEN PA
WAHREN B
Citation: K. Broliden et al., ANALYSES OF FUNCTIONAL ANTIBODY-RESPONSES IN HIV-1-INFECTED INDIVIDUALS AFTER VACCINATION WITH RGP160, Clinical and diagnostic virology, 6(2-3), 1996, pp. 115-126
Authors:
CALAROTA S
JANSSON M
LEVI M
BROLIDEN K
LIBONATTI O
WIGZELL H
WAHREN B
Citation: S. Calarota et al., IMMUNODOMINANT GLYCOPROTEIN-41 EPITOPE IDENTIFIED BY SEROREACTIVITY IN HIV TYPE 1-INFECTED INDIVIDUALS, AIDS research and human retroviruses, 12(8), 1996, pp. 705-713
Authors:
BROLIDEN K
VONGEGERFELT A
PERSSON C
HORAL P
SVENNERHOLM B
WAHREN B
BJORLING E
VAHLNE A
Citation: K. Broliden et al., IDENTIFICATION OF CROSS-REACTIVE ANTIGENIC TARGET REGIONS FOR HIV TYPE 1-SPECIFIC ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY, AIDS research and human retroviruses, 12(18), 1996, pp. 1699-1702
Authors:
BROLIDEN K
HINKULA J
TOLFVENSTAM T
NIPHUIS H
HEENEY J
Citation: K. Broliden et al., ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY TO CLINICAL ISOLATES OF HIV-1 AND SIVCPZ - COMPARISON OF HUMANS AND CHIMPANZEES, AIDS, 10(11), 1996, pp. 1199-1204
Citation: K. Broliden et al., ANTIGENIC TARGET SITES FOR HIV-1 SPECIFIC ANTIBODY-DEPENDENT CELLULARCYTOTOXICITY, Journal of cellular biochemistry, 1995, pp. 217-217
Authors:
BROLIDEN K
VONGEGERFELT A
WAHREN B
HORAL P
SVENNERHOLM B
JEANSSON S
VAHLNE A
Citation: K. Broliden et al., IDENTIFICATION OF ANTIGENIC TARGET REGIONS FOR HIV-1 SPECIFIC ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY, AIDS research and human retroviruses, 10, 1994, pp. 190000036-190000036
Authors:
VONGEGERFELT A
NILSSON C
PUTKONEN P
BROLIDEN K
Citation: A. Vongegerfelt et al., BROADLY REACTIVE HIV-2 AND SIVMAC SPECIFIC ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN IMMUNIZED AND INFECTED CYNOMOLGUS MONKEYS, Vaccine, 12(13), 1994, pp. 1203-1208
Authors:
PUTKONEN P
NILSSON C
WALTHER L
GHAVAMZADEH L
HILD K
BROLIDEN K
BIBERFELD G
THORSTENSSON R
Citation: P. Putkonen et al., EFFICACY OF INACTIVATED WHOLE HIV-2 VACCINES WITH VARIOUS ADJUVANTS IN CYNOMOLGUS MONKEYS, Journal of medical primatology, 23(2-3), 1994, pp. 89-94
Authors:
VONGEGERFELT A
DIAZPOHL C
FENYO EM
BROLIDEN K
Citation: A. Vongegerfelt et al., SPECIFICITY OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN SERA FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 2-INFECTED INDIVIDUALS, AIDS research and human retroviruses, 9(9), 1993, pp. 883-889
Authors:
VONGEGERFELT A
PUTKONEN P
FENYO EM
BROLIDEN K
Citation: A. Vongegerfelt et al., ADCC IN HIV-2 SIVMAC INFECTED INDIVIDUALS AND OR IMMUNIZED MONKEYS/, Journal of cellular biochemistry, 1993, pp. 72-72
Authors:
BROLIDEN K
SIEVERS E
TOVO PA
MOSCHESE V
SCARLATTI G
BROLIDEN PA
FUNDARO C
ROSSI P
Citation: K. Broliden et al., ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY AND NEUTRALIZING ACTIVITY INSERA OF HIV-1-INFECTED MOTHERS AND THEIR CHILDREN, Clinical and experimental immunology, 93(1), 1993, pp. 56-64